SB 833 revises Oklahoma’s rules for what medical expense evidence may be presented in personal injury trials. For past medical expenses, the bill generally makes the amount actually paid, rather than the amount originally billed, the admissible figure. It also allows evidence that a medical provider will accept the paid amount as full satisfaction of the obligation, and if a provider has filed a lien for more than the amount paid, the excess up to the lien amount may be admitted. If no payment has been made, the bill directs courts to use Medicare reimbursement rates in certain circumstances, again tied to evidence that the provider will accept that amount as full payment.
The bill also adds a new section governing future medical expenses in personal injury cases. For treatment not yet incurred, admissible evidence of reasonable value is limited to amounts actually necessary to satisfy the financial obligation for that treatment, and the evidence may not reference amounts above what could be paid by the plaintiff’s available health insurance or public/government health care program. If reimbursement rates cannot be determined, or if the injured party has no insurance or program eligibility, Medicare reimbursement rates become the only admissible amounts to establish the value of future treatment. The act applies prospectively to personal injury actions filed on or after its effective date, November 1, 2025, while the amended past-medical-expense rules are stated to apply to actions filed on or after November 1, 2015.
The bill’s impact is to narrow the range of medical billing evidence that plaintiffs may present to juries and to tie damages evidence more closely to amounts actually paid or payable under insurance, Medicare, or similar programs. It would affect personal injury plaintiffs, defendants, medical providers, and lienholders by limiting the use of gross billed charges and by potentially reducing recoverable medical damages in litigation. It also codifies a more uniform evidentiary framework for both past and future medical expenses in Oklahoma civil actions arising from personal injury.
The available voting history suggests the bill had meaningful support but not unanimity. It passed a Senate committee vote 7-2 and later cleared Senate third reading 29-18, indicating a divided chamber with a clear majority in favor. No committee transcripts were provided, so there is no recorded discussion to identify detailed arguments, but the vote margins suggest the bill was generally supported while still drawing opposition from some senators.
The likely points of contention are the bill’s treatment of medical damages and its reliance on Medicare or insurance reimbursement rates as benchmarks. Supporters would likely view the measure as a way to align trial evidence with actual economic loss and prevent inflated billed charges from being used in personal injury awards. Opponents would likely argue that it can understate the true value of medical care, disadvantage uninsured or underinsured plaintiffs, and shift litigation outcomes in favor of defendants and insurers by limiting admissible evidence of medical costs.
SB 833 amends 12 O.S. 2021, Section 3009.1, and creates new Section 3009.2 in Title 12 to change the admissibility rules for medical expense evidence in personal injury cases. It limits past medical expense evidence to amounts actually paid or otherwise accepted as full satisfaction, and it limits future medical expense evidence to amounts necessary to satisfy the obligation, often using Medicare reimbursement rates when insurance-based rates are unavailable or the plaintiff lacks coverage. The bill therefore affects personal injury litigation, medical lien claims, and the calculation of damages in Oklahoma courts.
The bill appears to have received generally favorable but divided support. It passed committee 7-2 and Senate third reading 29-18, showing that a majority of senators supported the measure while a substantial minority opposed it. With no committee transcript available, the record only shows the voting pattern, which suggests the bill was viewed as a significant tort-reform or damages-limiting proposal rather than a consensus change.
The main controversy is whether personal injury juries should hear billed charges or only the lower amounts actually paid or payable under insurance and Medicare schedules. Supporters likely favor the bill as a way to prevent inflated medical bills from driving awards and to standardize proof of damages. Opponents likely object that the bill can reduce compensation for injured plaintiffs, especially those without insurance, and that using Medicare rates may not reflect the real market value of care. The treatment of liens and the exclusion of amounts above insurance- or program-based reimbursement levels are also likely points of dispute.